Table 1

Baseline characteristics

Characteristics
Overall cases23 470
Age, median (IQR)40 (30–54)
Sex, N (%)
 Male11 008 (46.9)
 Female12 462 (53.1)
Date of treatment, N (%)
 20173957 (16.9)
 20186486 (27.6)
 20197568 (32.2)
 20205459 (23.3)
Season, N (%)
 Spring4473 (19.1)
 Summer5942 (25.3)
 Autumn6322 (26.9)
 Winter6733 (28.7)
Antibiotic regimens, N (%)
 Amoxicillin+furazolidone16 784 (71.5)
 Amoxicillin+clarithromycin4182 (17.8)
 Amoxicillin+levofloxacin309 (1.3)
 Furazolidone+clarithromycin1669 (7.1)
 Furazolidone+levofloxacin358 (1.5)
 Clarithromycin+levofloxacin95 (0.4)
 Others73 (0.3)
Duration, N (%)
 105641 (24.0)
 121060 (4.5)
 1416 769 (71.4)
Proton pump inhibitor, N (%)
 Rabeprazole10mg9654 (41.1)
 Rabeprazole20mg21 (0.1)
 Pantoprazole5815 (24.8)
 Esomeprazole4811 (20.5)
 Omeprazole2236 (9.5)
 Lansoprazole933 (4.0)